Navigation Links
StoredIQ Shares Expertise at IQPC's eDiscovery Pharma, Biotech and Medical Device Conference
Date:9/10/2009

AUSTIN, Texas, Sept. 10 /PRNewswire/ --

WHO: Panel of leading eDiscovery experts including Dan Junk, Esq., VP of Business Development, StoredIQ

WHEN: Tuesday, September 15th

9:50 a.m. ET

WHERE: IQPC's 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries

The Hub Cira Centre -- Philadelphia, PA

TOPIC: Cost-Benefit Analysis of In-house eDiscovery Tools vs. Outsourcing Help

DESCRIPTION:

Product liability lawsuits, patent disputes, class action claims, and regulatory investigations continue to challenge healthcare companies. IQPC's 4th Conference on eDiscovery for Pharma, Biotech & Medical Device Industries, focuses on eDiscovery and retention specifically for the highly regulated and litigious drug and medical device markets.

Addressing the cost and benefits of bringing eDiscovery in-house, StoredIQ's Vice President of Business Development, will take part in a panel discussion which includes Dr. Ellen Voorhees, TREC Project Manager from the National Institute of Standards and Technology and Huong Nyugen, Director of Intellectual Property from Impax Laboratories. Panel discussions will center on:

  • Examining how the eDiscovery tools and trends have changed and how they are evolving
  • Persuading the executive management the importance of eDiscovery readiness via a comprehensive cost-benefit analysis
  • Discussing impact of technology that is evolving faster than the laws and identifying areas of increasing importance when vetting eDiscovery technologies
  • Matching the right system with the right internal team

HOW: For more information about the conference and to register, visit: www.ediscoveryevent.com/pharma/

About StoredIQ

StoredIQ is a leading provider of enterprise-class Intelligent Information Management solutions, enabling organizations to gain visibility and control over business-critical information to help meet their compliance, governance and legal discovery requirements. The company provides a range of integrated solutions for fast response to litigation and investigations, for proactive "litigation readiness," and for information protection and risk management, as well as storage management. Industry-leading companies rely on StoredIQ's award-winning technology to streamline their information management and eDiscovery processes to reduce the risk, complexity and cost of litigation. For more information, visit www.storediq.com.

StoredIQ is a trademark of StoredIQ, Inc. All other trademarks may or may not be trademarks or registered trademarks of their respective owners.


'/>"/>
SOURCE StoredIQ
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. AspenBio Pharma Shares to Trade on the NASDAQ Capital Markets Exchange Under Symbol APPY
3. Neuralstem Shares Accepted for Trading on Amex(R)
4. Bionovo Announces the Pricing of Public Offering of Shares of Common Stock
5. Discas, Inc. Sells Shares to SNX Organic Fertilizers, Inc.
6. Essilor Cancels 700,000 Shares
7. Helix BioPharma announces $16.9 million private placement of common shares
8. Helix BioPharma closes $16.9 million private placement of common shares
9. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes
10. QED International Associates Announces Changes to the HealthShares(TM) Autoimmune-Inflammation and Neuroscience Indexes - Correction
11. QED International Associates Announces Changes to the HealthShares(TM) Composite, HealthShares(TM) Cancer and HealthShares(TM) Neuroscience Indexes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... CAMBRIDGE, Mass. , June 23, 2016 /PRNewswire/ ... the development of novel compounds designed to target ... compound, napabucasin, has been granted Orphan Drug Designation ... in the treatment of gastric cancer, including gastroesophageal ... cancer stemness inhibitor designed to inhibit cancer stemness ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... In a ... Hospital in Denmark detail how a patient who developed lymphedema after being treated for ... The results could change the paradigm for dealing with this debilitating, frequent side effect ...
(Date:6/23/2016)... , ... June 23, 2016 , ... ... exhibiting at the Pennsylvania Convention Center and will showcase its product’s latest features ... will also be presenting a scientific poster on Disrupting Clinical Trials in The ...
Breaking Biology Technology:
(Date:3/23/2016)... WAKEFIELD, Massachusetts , March 23, 2016 ... kombiniert im Interesse erhöhter Sicherheit Gesichts- und ... Xura, Inc. (NASDAQ: MESG ... heute bekannt, dass das Unternehmen mit SpeechPro ... insbesondere aus der Finanzdienstleistungsbranche, wird die Möglichkeit ...
(Date:3/22/2016)... PROVO and SANDY, Utah ... Ontario (NSO), which operates the highest sample volume laboratory ... and Tute Genomics and UNIConnect, leaders in clinical sequencing ... announced the launch of a project to establish the ... panel. NSO has been contracted by ...
(Date:3/18/2016)... --> --> Competitive Landscape ... Vehicles, Physical infrastructure and Perimeter Surveillance & Detection Systems ... market and the continuing migration crisis in the ... has led visiongain to publish this unique report, which is ... & security companies in the border security market and ...
Breaking Biology News(10 mins):